Fund HoldingsStonepine Capital Management, LLC

Total Portfolio Value
$231.23M
Total Bought
$25.86M
Total Sold
$96.36M
Net Transaction
-$70.50M
Filing Period:
Securities
SharesValue ($K)
Q3 2023
Q4 2023
Change
Q3 2023
Q4 2023
Weight (%)
Change
ADMA BIOLOGICS INC9,104,2759,222,617+118,34232,59341,68618.03%+9,093
EVOLUS INC5,179,0045,333,004+154,00047,33656,15724.29%+8,820
ALIMERA SCIENCES INC3,983,6863,999,459+15,77312,34917,2787.47%+4,928
XERIS BIOPHARMA HOLDINGS INC5,915,3725,937,000+21,62811,00313,9526.03%+2,949
IO BIOTECH INC1,975,3081,666,037-309,2712,7853,1321.35%+347
AYTU BIOPHARMA INC472,369472,469+1001,2751,3420.58%+66
REZOLUTE INC3,072,4762,768,656-303,8204,0562,7481.19%-1,308
XOMA CORP436,602250,000-186,6026,1524,6252.00%-1,527
EXAGEN INC1,203,491669,684-533,8072,9121,3330.58%-1,580
TELA BIO INC491,919317,782-174,1373,9352,1040.91%-1,832
VANDA PHARMACEUTICALS INC477,9030-477,9032,0650-2,065
ASSERTIO HOLDINGS INC951,1970-951,1972,4350-2,435
ATEA PHARMACEUTICALS INC1,720,000839,514-880,4865,1602,5611.11%-2,599
DELCATH SYSTEMS INC686,2400-686,2402,7790-2,779
GOSSAMER BIO INC3,339,4050-3,339,4052,7810-2,781
SCYNEXIS INC2,852,5991,355,186-1,497,4136,5043,0221.31%-3,482
X4 PHARMACEUTICALS INC5,273,6850-5,273,6855,7480-5,748
ATYR PHARMA INC4,626,624482,258-4,144,3667,3106800.29%-6,630
GAMIDA CELL LTD7,965,8650-7,965,8658,2050-8,205
AMYLYX PHARMACEUTICALS INC(AMLX)2,515,8682,500,000-15,86846,06636,80015.92%-9,266
MAXCYTE INC3,761,6400-3,761,64011,7360-11,736
QUIDELORTHO CORP(QDEL)658,794450,000-208,79448,11833,16514.34%-14,953
GALAPAGOS NV-SPON ADR(LKFT)802,544261,870-540,67427,72810,6454.60%-17,083
Page 1 of 1